EDITORIAL MESSAGE.
| Published in: | Innovations in Clinical Neuroscience Vol. 15; no. 5/6; p. 3 |
|---|---|
| Main Author: | |
| Format: | editorial Journal Article |
| Published: |
Matrix Medical Communications, LLC
May/Jun2018
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=130481103&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 130481103 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 21588333 DAD5 jtl: Innovations in Clinical Neuroscience issn: 21588333 maglogo: N pubinfo: dt: May/Jun2018 vid: 15 iid: 5/6 pid: 33670 pub: Matrix Medical Communications, LLC place: West Chester, Pennsylvania artinfo: ui: 130481103 130481103 130481103 130481103 ppf: 3 ppct: 0 formats: fmt: @attributes: type: P tig: atl: EDITORIAL MESSAGE. aug: au: Kalali, Amir sug: subj: Dyskinesia, Drug-Induced Drug Therapy Membrane Proteins Therapeutic Use Drug Approval United States Food and Drug Administration Drug Interactions Serial Publications Amphetamines Therapeutic Use Topiramate Therapeutic Use Binge Eating Disorder Drug Therapy Dextroamphetamine Pharmacodynamics Functional Status Hyperglycemia Complications Delirium Etiology Psychotic Disorders Etiology Stigma Machine Learning Health Behavior Atrial Fibrillation Aripiprazole Administration and Dosage Schizoaffective Disorder Drug Therapy Risk Management Suicide, Attempted pubtype: Academic Journal doctype: editorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|